Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.

MLA

Keeney, Edna, et al. “Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.” PharmacoEconomics, vol. 40, no. 12, Dec. 2022, pp. 1207–20. EBSCOhost, https://doi.org/10.1007/s40273-022-01191-1.

APA

Keeney, E., Sanghera, S., Martin, R. M., Gulati, R., Wiklund, F., Walsh, E. I., Donovan, J. L., Hamdy, F., Neal, D. E., Lane, J. A., Turner, E. L., Thom, H., & Clements, M. S. (2022). Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial. PharmacoEconomics, 40(12), 1207–1220. https://doi.org/10.1007/s40273-022-01191-1

Chicago

Keeney, Edna, Sabina Sanghera, Richard M Martin, Roman Gulati, Fredrik Wiklund, Eleanor I Walsh, Jenny L Donovan, et al. 2022. “Cost-Effectiveness Analysis of Prostate Cancer Screening in the UK: A Decision Model Analysis Based on the CAP Trial.” PharmacoEconomics 40 (12): 1207–20. doi:10.1007/s40273-022-01191-1.